1370-1371 / 2437
Treatment concepts of the children cannot be adopted
one by one for adults, studies are needed.
Actual Standard
postop. RT CSI 36 Gy / 54 Gy boost PF
(Boost only to the Tumor ?)
Dose reduction is not possible at the moment
Chemotherapy for „Standard risk „ ?
Feasibility and effectiveness?
New Concepts ? RT- CT ?
CT- Protocol for „High risk“ ?
Medulloblastoma in Adults
Conclusion
Molecular markers for choosing individual MB Therapy
Molecular markers and the concept of biological Risk Profile will
Influence MB Therapy .